{
    "nctId": "NCT04873154",
    "briefTitle": "CD133 Expression in Mammary Invasive Ductal Carcinoma",
    "officialTitle": "Significance of CD133 Expression in Invasive Ductal Carcinoma of the Breast",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 50,
    "primaryOutcomeMeasure": "1. Detect the immunohistochemical expression of CD133 in mammary invasive ductal carcinoma (IDC) and to correlate its expression with some known clinicopathological parameters.",
    "eligibilityCriteria": "Inclusion Criteria:\u2022 Inclusion criteria: Patients with IDC and underwent mastectomy or excisional biopsy of breast mass.\n\n-\n\nExclusion Criteria\n\n* Patients received pre-operative chemotherapy or radiotherapy.\n* Patients with insufficient clinical data.",
    "sex": "FEMALE",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}